Home > PS Ratio > ADVANCED ENZYME TECHNOLOGIES

ADVANCED ENZYME TECHNOLOGIES
PS (Price/Sales) Ratio

The Current P/S Ratio of ADVANCED ENZYME TECHNOLOGIES is 4.93.

Share Price ₹276.3Mar 11,2025
Market Cap ₹3,091.8 Cr
Sales-TTM₹627.5 CrTTM-Consolidated Results
Price/Sales4.93xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for ADVANCED ENZYME TECHNOLOGIES
Please provide your vote to see the results
ADVANCED ENZYME TECHNOLOGIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of ADVANCED ENZYME TECHNOLOGIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of ADVANCED ENZYME TECHNOLOGIES is calculated as :

Current Market Cap [ ₹3,091.8 Cr] as on Mar 11,2025

(/) Sales [ ₹627.5 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 4.93x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '4.93 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of ADVANCED ENZYME TECHNOLOGIES !

The chart below summarizes the trend in P/S Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.

Historical PS (Price/Sales) ratio chart of ADVANCED ENZYME TECHNOLOGIES


PS Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES

- ADVANCED ENZYME TECHNOLOGIES 's latest p/e ratio is 4.93x.

- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.65x.

- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 5.96x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2021 at 7.68x.

- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2020 of 3.6x.


How does ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
ADVANCED ENZYME TECHNOLOGIES 627.54.933,091.8
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.70397,246.0
DIVIS LABORATORIES LTD9,078.016.21147,119.0
CIPLA LTD26,981.24.33116,805.0
TORRENT PHARMACEUTICALS LTD11,302.09.16103,554.0
DR REDDYS LABORATORIES LTD31,229.32.9893,192.0
MANKIND PHARMA LTD11,641.07.8391,196.4
ZYDUS LIFESCIENCES LTD22,247.44.0790,551.0
LUPIN LTD22,001.64.1090,226.2
AUROBINDO PHARMA LTD30,921.82.0563,368.4
ABBOTT INDIA LTD6,243.210.3864,826.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.05x
Max industry PS 16.21x
Median industry PS 4.93x
Average industry PS 6.70x



You may also like the below Video Courses